Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study.

MLA

Robinson, N., et al. “Interleukin-2 after Autologous Stem Cell Transplantation for Hematologic Malignancy: A Phase I/II Study.” Bone Marrow Transplantation, vol. 19, no. 5, Mar. 1997, p. 435. EBSCOhost, https://doi.org/10.1038/sj.bmt.1700687.

APA

Robinson, N., Benyunes, M. C., Thompson, J. A., York, A., Petersdorf, S., Press, O., Lindgren, C., Chauncey, T., Buckner, C. D., Bensinger, W. I., Appelbaum, F. R., & Fefer, A. (1997). Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study. Bone Marrow Transplantation, 19(5), 435. https://doi.org/10.1038/sj.bmt.1700687

Chicago

Robinson, N, M C Benyunes, J A Thompson, A York, S Petersdorf, O Press, C Lindgren, et al. 1997. “Interleukin-2 after Autologous Stem Cell Transplantation for Hematologic Malignancy: A Phase I/II Study.” Bone Marrow Transplantation 19 (5): 435. doi:10.1038/sj.bmt.1700687.